Amorphous Drug Nanosuspensions. 1. Inhibition of Ostwald Ripening
- 21 December 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 22 (3), 906-910
- https://doi.org/10.1021/la0523661
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Amorphous Drug Nanosuspensions. 2. Experimental Determination of Bulk Monomer ConcentrationsLangmuir, 2005
- Formation of Colloidal Dispersions of Organic Materials in Aqueous Media by Solvent ShiftingLangmuir, 2003
- Liquid Droplet Dispersions Formed by Homogeneous Liquid−Liquid Nucleation: “The Ouzo Effect”Langmuir, 2003
- Nanosizing: a formulation approach for poorly-water-soluble compoundsEuropean Journal of Pharmaceutical Sciences, 2003
- Drug-like properties and the causes of poor solubility and poor permeabilityJournal of Pharmacological and Toxicological Methods, 2000
- Differential Molar Heat Capacities to Test Ideal Solubility EstimationsPharmaceutical Research, 1997
- Ostwald ripening theory: applications to fluorocarbon emulsion stabilityAdvances in Colloid and Interface Science, 1992
- Ostwald ripening in two-component disperse phase systems: Application to emulsion stabilityColloids and Surfaces, 1987
- Über die vermeintliche Isomerie des roten und gelben Quecksilberoxyds und die Oberflächenspannung fester KörperZeitschrift für Physikalische Chemie, 1900